SHIBUYA CORPORATION (6340) Stock Price

Market cap
¥99.4B
P/E ratio
10.5x
Shibuya Industrial manufactures production line equipment for beverages, food, and pharmaceuticals, plus mechatronic devices for semiconductors and medical uses.

Price and Volume

Market Cap

Subscribe to premium to access
Market Cap.

Check pricing

PER

Subscribe to premium to access
PER.

Check pricing

PBR

Business Overview

Shibuya Industrial designs, manufactures, and sells equipment for production lines in beverages, food, and pharmaceuticals, as well as mechatronic devices for semiconductors and medical applications, and sorting and grading equipment for agriculture. The company's core products include bottling systems for filling, capping, and labeling, as well as case forming, packaging, and cleaning equipment, along with clean room facilities for pharmaceutical manufacturing and regenerative medicine.

The company serves major customers including food and beverage manufacturers, pharmaceutical companies, semiconductor manufacturers, medical device makers, and agricultural operators. In addition to selling machinery, the company generates revenue through installation, adjustment, maintenance, and parts supply services. With domestic operations and subsidiaries in North America, China, and Southeast Asia, the company receives orders and delivers products globally, with overseas sales representing an important revenue pillar.

The company's business consists of three pillars: the Packaging Plant Business, the Mechatronic Systems Business, and the Agricultural Equipment Business. In packaging, the company handles filling, capping, and labeling equipment, as well as pharmaceutical machinery and cell culture devices for regenerative medicine. In the mechatronic field, the company offers a range of products including semiconductor manufacturing equipment, medical lasers, cutting machines, and hydraulic presses.

Management Policy

Under its medium-term management plan covering the fiscal years ending June 2025 through June 2027, the company aims to achieve revenue of 150 billion yen, operating profit of 16 billion yen, and ROE of 10% or higher by the final year. The company has also set a long-term target of 2 trillion yen in revenue by June 2030, establishing a clear growth trajectory with defined numerical targets. To achieve these goals, the company's basic strategy is to pursue both improved profitability in existing businesses and development of new business areas in parallel.

Priority investment areas span packaging (aseptic filling and others), mechatronics (medical and semiconductor equipment), agricultural equipment, and regenerative medicine systems. The company holds a strong domestic market share in aseptic filling for beverages (estimated at approximately 80–90%) and differentiates itself through specialized equipment and high-value-added products in regenerative medicine and semiconductor fields. Beyond product sales, the company is strengthening services including installation, maintenance, and parts supply, investing in a business model that generates profits through long-term customer relationships.

In developing new markets, the company prioritizes international expansion and new business creation. Given the high overseas ratio for artificial dialysis equipment, the company is expanding medical device manufacturing capacity (including expansion of the Wakamiya plant) to capture overseas demand and increase sales in Asia and North America. Additionally, the company aims to capture demand from beverage market growth in emerging nations and from agricultural applications through the adoption of AI-powered image processing sorting systems. The company will also strategically utilize M&A as needed to expand its business globally.

Regarding technological innovation, the company emphasizes creating new products through industry-academia-government collaboration and strengthening internal development capabilities. In regenerative medicine, the company is working with universities and startups to develop mass-production-capable equipment. In packaging, it is differentiating through environmentally friendly technologies such as electron beam bottle sterilization methods. By implementing digitalization (DX) of operations and product development, AI-powered image processing, and transport and robotics technologies, the company aims to establish a system for short lead times and high quality, simultaneously enhancing customer value and sustainability.

AI Chat